Clinical Trial Detail

NCT ID NCT02834780
Title Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H3 Biomedicine Inc.
Indications

hepatocellular carcinoma

intrahepatic cholangiocarcinoma

Therapies

H3B-6527

Age Groups: adult senior

No variant requirements are available.